β1受体反义基因治疗对肾性高血压大鼠心脏的保护作用

中国临床药理学与治疗学 ›› 2005, Vol. 10 ›› Issue (10): 1123-1127.

β₁受体反义基因治疗对肾性高血压大鼠心脏的保护作用

伍远雄¹, 王晋明, 张美春¹, 梁远红

武汉大学人民医院心内科, 武汉 430060, 湖北;
¹武汉湖北省总队医院心内科, 武汉 430061, 湖北

收稿日期:2005-07-16 修回日期:2005-09-09 发布日期:2020-11-23
通讯作者: 王晋明,男、教授、主任医师,博士生导师,主要从事高血压病、冠心病、心律失常及心力衰竭的临床和基础研究。Tel:13871487767 E-mail:wang_jinming@163.com
作者简介:伍远雄,男,博士研究生,主要从事高血压的基础研究及高血压和冠心病的临床诊治。Tel:027-62197805 E-mail:wyx555@126.com

Protection effect of β₁ receptor mRNA antisense inhibition on heart of renal hypertensive rats

Wuyuan-xiong, WANG Jin-ming, ZHANG Mei-chun, LIANG Yuan-hong

Department of Cardiology, Rennin Hospital, Wuhan University, Wuhan 43006, Huei, China

Received:2005-07-16 Revised:2005-09-09 Published:2020-11-23

摘要/Abstract

摘要： 目的: 探讨阳离子脂质体混合物介导的β₁受体反义基因对肾性高血压大鼠血压和心脏的影响及机制。方法: 将24只雄性SD大鼠随机分成4组(n=6):两肾一夹模型组(2K1C组),两肾一夹模型+反义核苷酸组(尾静脉β₁-AS-ODN 0.5 mg·kg^-1,反义组),两肾一央模型+反向核苷酸组(尾静脉β₁-IN-ODN 0.5 mg·kg^-1,反向组),假手术组。常规方法测定尾动脉收缩压、左室血流动力学指标及左心室重量指数(LVMI),以光镜观察心肌组织变化,免疫组织化学方法检测心肌Bcl-2、 Bax的表达。结果: 单剂反义寡核苷酸治疗可持续降压27 d,血压最低可降至120 mmHg左右;并可明显改善左室收缩、舒张功能;反义组的左室重量指数也显著低于2K1C组(P<0.01);心肌细胞病理变化也较2K1C 组改善;2K1C组心肌Bcl-2/Bax比值明显低于假手术组,而反义组与2K1C组相比,Bcl-2/Bax比值明显升高 (P<0.05)。结论: 以β受体为靶基因的反义基因单剂治疗在有效而持久的控制肾性高血压的同时,可显著逆转左室肥厚,改善左室功能,其机制可能与升高Bcl-2/Bax比值、抑制心肌细胞凋亡相关。说明β受体反义基因治疗对肾性高血压大鼠具有心脏保护作用。

关键词: 肾性高血压, 反义寡核苷酸, β₁肾上腺素能受体, 基因治疗, 左室肥厚, 心脏保护, 凋亡Bel-2/Bax

Abstract: AIM: To explore the effect and mechanism on blood pressure and heart protection of renal hypertension in rats treated with β₁ receptor antisense oli-godeoxynucleotides (β₁-AS-ODN) by delivery with cation-icliposomes DOTAP/DOPE.METHODS: 24 SD rats were divided randomly into 4 groups of 6 each group two groups of 2KIC rats were treated via tail vein injection with β₁-AS-ODN or inverted oli gonucleotides against rat β₁-AR MNA (β₁-IN-ODN) of 0.5 mg·kg^-1 once. 6 unltreated 2K1C rats and shamed rats served as positive andnormal controls. Blood pressure (BP), cardiac haemodynamics, and left ventricular index (LVW/BW) were measured. The histological changes of myocardium were observed by optical microscope and the expressions of Bcl-2 and Bax in myocardium were examined by immunohistochemical method.RESULTS: The single dose management of β₁-AS-ODN decreased blood pressure to 120 mm-Hg for 27 days and improved the LV function obviously P < 0.01). The value of LVW/BW in β₁-AS-ODN oup is much less than the value of that in 2K1C group(P 0.01). Compared with that of 2K1C group, thethological changes of myocardium inβ₁-AS-ODN groupmeliorated. The radio of bcl-2/Bax in 2KIC group wasless than sham group, and the radio of that in β₁-AS-ODN group was more than 2KIC group (P < 0. 05).CONCLUSION: β₁ receptor antisense oligodeoxynucleotidescan maintain anti-hypertension effect for atime and improve LV function, effectively reverses left ventricular hypertrophy in 2K1C renal hypertensive rats. The mecha-nism of which may be related to the suppressing of cell apoptosis of myocardium by increasing Bcl-2/Bax. It sug-gests that, receptor mRNA antisense had the heart protection effect in renal hypertensive raf.

Key words: renal hypertension, antisense oligonucleotides, β₁-adrenergic receptor, gene therapy, left ventricular hypertrophy, heart protection, apotosis, Bcl-2/Bax

中图分类号:

R965.1

伍远雄, 王晋明, 张美春, 梁远红. β₁受体反义基因治疗对肾性高血压大鼠心脏的保护作用[J]. 中国临床药理学与治疗学, 2005, 10(10): 1123-1127.

Wuyuan-xiong, WANG Jin-ming, ZHANG Mei-chun, LIANG Yuan-hong. Protection effect of β₁ receptor mRNA antisense inhibition on heart of renal hypertensive rats[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2005, 10(10): 1123-1127.

参考文献

1 Phillips MI, Galli SM, Mehta JL. The potential role of antisense oligodeoxynucleotide therapy for carardiovascular disease[J]. Drugs, 2000; 60: 239-48
2 Zhang YC, Bui J D, Shen L, Phillips MI. Antisense inhibition of β₁-adrenoceptor mRNA in a single dose produces a profound and prolonged reduction in high blood pressure in spontaneously hypertensive rats[J]. Circulation, 2000: 101: 682-8
3 Emmanuel T, Than-V D, Lucie R, Claudine W, Bun-seng TLouis G, et al. Apoptosis in pressure overload-induced heart pertrophy in the rat[J]. Clin Invest, 1996: 97: 2891-7
4 Grassi G. Role of the sympathetic nervous system in human hypertension [J]. Hypertension, 1998; 16: 1979-87
5 Catherine C, Krishna S, David R. Pimentel, Wilson S, Colucci. Norepinephrine stimulates apoptosis in adult rat ventricular myocytes by activation of the β-Adrenergic Pathway [J]. Circulation, 1998;98: 1329-34
6 Michael Z, Weimin X, Eliana L, Saiyid A, Shafiq, Nasir Z, et al. β-adrenergic receptor subtypes differentially affect apoptosis in adult rat ventricular myocytes [J]. Circulation, 2000; 102: 344
7 Gu C, Ma YC, Benjamin J, Littman D, Chao MV, Huang XY. Apoptosis signaling through the a-adrenergic receptor, a new Gseffctor pathway [J]. J Biol Chem, 2000; 275: 20726-33
8 Phillips MI. Gene therapy for hypertension: the preclinical data9 Vacek M, Sazani P, Kole R. Antisense-mediated redirection of MRNA splicing [J]. Hypertension, 2001; 38: 543-8
9 Vacek M. Sazani P, Kole R. Antisense-mediated redirection of mRNA splicingl[J]. Cell Mol Life Sci, 2003: 60: 825-33
10 Maino G, Joris I. Apoptosis, oncosis, and necrosis. An over view of cell death [J]. Am J Pathol, 1995; 146: 3
11 Adams JM, Cory S. The Bcl-2 protein family: arbiter of cell survival [J]. Science, 1998: 281: 1322
12 Oltvai ZN, Korsmeyer SJ. Checkpoints of dueling dimmers foil death wishes [J]. Cell, 1994; 79: 189
13 Yuan JY, Molecular control of life and death [J]. Curr Opin Cell Biol. 1995: 7: 211
14 Gianluigi C, Carmine M, Giorgio S, Antonella N, Felicia F, Gisepp S, et al. Increased cardiomyocyte apoptosis and changes in proapoptotic and antiapoptotic genes ax and Bcl-2 during left ventricular adaptations to chronic pressure overload in the rat [J]. Circulation, 1999; 99: 3071-78

[1]	卢森林, 刘欣元, 王吉莉, 黄晓飞. 病毒载体介导的基因治疗在2型糖尿病中的研究进展[J]. 中国临床药理学与治疗学, 2022, 27(7): 800-807.
[2]	姜兵兵. microRNA在亨廷顿病中的研究进展[J]. 中国临床药理学与治疗学, 2020, 25(6): 677-685.
[3]	邓祖跃. 虾青素对Beagle犬心肌梗死模型的保护作用及其降低氧化应激机制[J]. 中国临床药理学与治疗学, 2016, 21(5): 509-513.
[4]	贾建光，郭晨旭，李靖，张立功，王益民，全志伟，钱军. 腺病毒介导的MDA-7/IL-24基因对裸鼠胆囊癌移植瘤的生长抑制和促凋亡作用[J]. 中国临床药理学与治疗学, 2015, 20(11): 1221-1226.
[5]	周燕琼, 张艳美, 高分飞, 黄展勤, 陈一村, 郑燕珊, 石刚刚. 反义寡核苷酸抑制早期生长反应基因-1表达对内皮细胞缺氧复氧损伤的影响[J]. 中国临床药理学与治疗学, 2015, 20(1): 14-18.
[6]	李征, 向开敏, 彭淑平, 李桂源. MicroRNA-34用于肿瘤治疗的基础研究[J]. 中国临床药理学与治疗学, 2014, 19(1): 67-73.
[7]	汪祥海, 魏强, 王晓彤, 查林涛, 杨玉雯. 携带人S100A1基因的重组腺相关病毒载体的构建及鉴定[J]. 中国临床药理学与治疗学, 2013, 18(8): 853-857.
[8]	孔祥, 杨解人, 郭莉群, 周勇. 芝麻素对肾性高血压伴高血脂大鼠主动脉舒张功能的影响[J]. 中国临床药理学与治疗学, 2013, 18(4): 366-370.
[9]	吕颖慧, 龚玉华, 刁勇, 许瑞安, 王启钊. 高迁移率族蛋白A2在肿瘤发生和血管形成中的双重作用[J]. 中国临床药理学与治疗学, 2011, 16(9): 975-980.
[10]	刘慕君, 刘艳平, 刘雄昊. 血友病A的基因治疗[J]. 中国临床药理学与治疗学, 2010, 15(8): 932-937.
[11]	刘扬, 吴金明, 金思思, 申苏建, 吴利敏, 江宏峰, 金颖. 假单胞菌外毒素体外靶向抗肝细胞癌的实验研究[J]. 中国临床药理学与治疗学, 2010, 15(4): 372-375.
[12]	范剑峰, 汤圣兴, 王俊, 朱卫平, 李必龙, 朱正才. 原发性高血压左室肥厚患者妊娠相关血浆蛋白-A和C-反应蛋白的变化[J]. 中国临床药理学与治疗学, 2009, 14(2): 203-206.
[13]	徐海红, 杨利才, 杨沿浪, 张道友. 缬沙坦降低慢性肾衰竭大鼠心肌内皮素的表达[J]. 中国临床药理学与治疗学, 2008, 13(6): 639-643.
[14]	李玉梅, 朱学慧, 袁恒杰, 罗琼, 吴艳娜, 康毅, 焦建杰, 高卫真, 刘艳霞, 娄建石. 无创性延迟肢体缺血预适应对糖尿病大鼠心肌缺血/再灌注氧化损伤的影响[J]. 中国临床药理学与治疗学, 2008, 13(11): 1220-1225.
[15]	王启钊, 吕颖慧, 许瑞安. 基因治疗用腺相关病毒载体的剂量效应与剂量控制[J]. 中国临床药理学与治疗学, 2008, 13(10): 1182-1194.

β₁受体反义基因治疗对肾性高血压大鼠心脏的保护作用

Protection effect of β₁ receptor mRNA antisense inhibition on heart of renal hypertensive rats

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价